Myasthenia gravis. Therapy
Cornejo Barrera, M.; Pérez Ramirez, J.L.; Pérez Mijares, R.; Neira Salaverria, F.; Damiano Rivero, A.
Revista Clinica Espanola 144(3): 227-235
1977
ISSN/ISBN: 0014-2565 PMID: 841152 Document Number: 121949
Document emailed within 1 workday
Related Documents
Szobor, A. 1989: Myasthenia gravis: familial occurrence. A study of 1100 myasthenia gravis patients Acta Medica Hungarica 46(1): 13-21Vincent, A.; Newsom-Davis, J. 1982: Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset Clinical and Experimental Immunology 49(2): 266-272
Ritzow, E.; Cierpka, G.; Ritzow, H.; Kwiatkowski, E.; Feyerherd, F. 1975: Electromyography and intensive therapy in myasthenia gravis Zeitschrift für Arztliche Fortbildung 69(12): 636-638
Morimoto, M.; Haginoya, K. 2016: Meet the experts: therapy of myasthenia gravis in childhood No to Hattatsu 48(2): 98-100
Morimoto, M.; Haginoya, K. 2016: Meet the experts: therapy of myasthenia gravis in childhood No to Hattatsu 48(2): 98-100
Tanaka, J.; Matsuzaki, K.; Arai, H.; Nagai, T.; Matsumoto, Y.; Okada, S. 1994: Intermittent methylprednisolone pulse therapy for myasthenia gravis in childhood No to Hattatsu 26(1): 14-19
Marsh, D.O. 1974: Adrenal therapy for neuromuscular disease including myasthenia gravis from 1896 New York State Journal of Medicine 74(11): 1974-1976
Li, L.; Zhang, Y.P. 1994: Therapy of experimental autoimmune myasthenia gravis in rabbits with 4-aminopyridine and 3,4-diaminopyridine Zhongguo Yao Li Xue Bao 15(4): 358-362
Chu, C.C.; Huang, C.C. 1996: Low-dose intravenous immunoglobulin therapy in myasthenia gravis: a case report Zhonghua Yi Xue Za Zhi 57(3): 232-235
Heininger, K.; Fateh-Moghadam, A.; Toyka, K.V.; Besinger, U.A.; Witthöft, J. 1980: Significance of acetylcholine receptor antibody in the diagnosis and therapy monitoring of myasthenia gravis La Ricerca in Clinica E in Laboratorio 10(1): 255-258
Lechin, F.; van der Dijs, B.; Pardey-Maldonado, B.; John, E.; Jimenez, V.; Orozco, B.; Baez, S.; Lechin, M.E. 2000: Enhancement of noradrenergic neural transmission: an effective therapy of myasthenia gravis: a report on 52 consecutive patients Journal of Medicine 31(5-6): 333-361
Nau, R.; Behrends, T.; Henze, T.; Prange, H.W. 1989: Central nervous system infection caused by Aspergillus fumigatus. A complication of immunosuppressive therapy in myasthenia gravis Der Nervenarzt 60(3): 178-180
Kanzaki, M.; Obara, T.; Sasano, S.; Hikawa, Y.; Onuki, T. 2008: Long-term clinical outcome after extended thymectomy combined postoperative high-dose steroid therapy for juvenile myasthenia gravis Annals of Thoracic and Cardiovascular Surgery: Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 14(2): 119-122
Pirskanen, R. 1975: Myasthenia gravis Duodecim; Laaketieteellinen Aikakauskirja 91(6): 309-312
Mozai, T.; Masui, Y. 1982: Myasthenia gravis Nihon Rinsho. Japanese Journal of Clinical Medicine 40(7): 1571-1576
Tanaka, K. 2004: Myasthenia gravis Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 5): 580-585
Téllez Zenteno, J.F.; Morales Buenrostro, L.E.; Torre Delgadillo, A. 2000: Pathogenesis of myasthenia gravis Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 52(1): 80-85
Vora, A.; Chacko, J.G. 2013: Paraneoplastic myasthenia gravis Journal of the Arkansas Medical Society 109(9): 180-182
Gajdos, P. 2004: Seronegative myasthenia gravis Revue Neurologique (Paris) 160(2): 159-162
Martínez Castrillo, J.C.; Mariscal, A. 1993: Treatment of myasthenia gravis Medicina Clinica 101(18): 693-696